Loading
A phase 2 trial of Endoscopic resection in Nasal cavity and paranasal sinus cancers, run by Memorial Sloan Kettering Cancer Center, completed.
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages is a phase 2 interventional study registered as NCT03274414 by Memorial Sloan Kettering Cancer Center, with 3 participants recorded, started 2017-09-01 and reaching its primary completion in 2023-01-13. Interventions recorded: Cisplatin, Adjuvant Proton Radiotherapy, Endoscopic Resection, cisplatin and etoposide. Conditions recorded: Paranasal Sinus Cancer, Nasal Cavity Tumor, Nasal Cavity Adenocarcinoma.
Linked to the technology Endoscopic resection because the registry names it ("endoscopic resection") among its interventions and Nasal cavity and paranasal sinus cancers among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Endoscopic resection (EMR / ESD) and the tag pipeline.
Shares Endoscopic resection (EMR / ESD) and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Shares Cisplatin and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/